RALTEGRAVIR

RALTEGRAVIR was reported 5248 times

RALTEGRAVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ULTRASOUND ANTENATAL SCREEN 53 0.5521
1 CLOACAL EXSTROPHY 32 0.5424
2 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 68 0.5271
3 BLADDER AGENESIS 33 0.4459
4 CRITICAL ILLNESS MYOPATHY 9 0.3750
5 LENTICULOSTRIATAL VASCULOPATHY 9 0.3462
6 GASTROINTESTINAL DISORDER CONGENITAL 32 0.3019
7 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 10 0.2703
8 CAUDAL REGRESSION SYNDROME 41 0.2628
9 AIDS DEMENTIA COMPLEX 15 0.2459
10 ECTOPIC KIDNEY 23 0.2421
11 HIV ASSOCIATED NEPHROPATHY 12 0.2353
12 HEMIVERTEBRA 38 0.2249
13 CSF HIV ESCAPE SYNDROME 30 0.2174
14 CONGENITAL ECTOPIC BLADDER 10 0.2083
15 CONGENITAL GENITAL MALFORMATION 31 0.1938
16 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 21 0.1892
17 GENITALIA EXTERNAL AMBIGUOUS 31 0.1792
18 CONGENITAL MUSCULOSKELETAL DISORDER OF SPINE 9 0.1765
19 MECONIUM STAIN 27 0.1753
20 AIDS ENCEPHALOPATHY 10 0.1724
21 PHALANGEAL HYPOPLASIA 12 0.1690
22 TETHERED CORD SYNDROME 30 0.1357
23 BLOOD HIV RNA INCREASED 214 0.1179
24 MITOCHONDRIAL TOXICITY 96 0.1169
25 CONGENITAL PULMONARY VALVE DISORDER 12 0.1165
26 VIROLOGIC FAILURE 587 0.1090
27 THYMUS ENLARGEMENT 17 0.1062
28 GASTROINTESTINAL MALFORMATION 22 0.1053
29 CONGENITAL VESICOURETERIC REFLUX 9 0.1047
30 BONE DEMINERALISATION 110 0.1039
31 CONGENITAL MUSCULOSKELETAL DISORDER 9 0.1034
32 LIPODYSTROPHY ACQUIRED 217 0.1021
33 HIV VIRAEMIA 21 0.1000
34 TRISOMY 18 38 0.0997
35 SPINE MALFORMATION 34 0.0980
36 BRACHYDACTYLY 19 0.0964
37 BACTERIAL VULVOVAGINITIS 26 0.0900
38 NEONATAL RESPIRATORY ARREST 13 0.0890
39 PLAGIOCEPHALY 44 0.0882
40 DEXTROCARDIA 16 0.0851
41 VIRAL MUTATION IDENTIFIED 308 0.0835
42 VIRAL LOAD DECREASED 12 0.0822
43 EXOMPHALOS 44 0.0819
44 ANOGENITAL DYSPLASIA 12 0.0800
45 CONGENITAL MITRAL VALVE INCOMPETENCE 11 0.0786
46 RENAL DYSPLASIA 29 0.0749
47 PSYCHIATRIC DECOMPENSATION 140 0.0716
48 CONGENITAL HEART VALVE DISORDER 17 0.0714
49 MENINGOMYELOCELE 42 0.0700
50 CONGENITAL CHOROID PLEXUS CYST 21 0.0689
51 HYDROPS FOETALIS 41 0.0669
52 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 20 0.0597
53 UMBILICAL CORD ABNORMALITY 31 0.0588
54 CHOLESTASIS OF PREGNANCY 27 0.0587
55 CONGENITAL SKIN DIMPLES 14 0.0581
56 ANAL ATRESIA 31 0.0581
57 IMMUNE RECONSTITUTION SYNDROME 73 0.0565
58 DIASTASIS RECTI ABDOMINIS 9 0.0559
59 HETEROTAXIA 9 0.0539
60 GENOTYPE DRUG RESISTANCE TEST POSITIVE 55 0.0535
61 GENITAL HERPES SIMPLEX 11 0.0519
62 MONKEYPOX 14 0.0507
63 BRAIN STEM STROKE 25 0.0507
64 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 251 0.0503
65 OESOPHAGEAL ATRESIA 31 0.0496
66 SUDDEN INFANT DEATH SYNDROME 24 0.0488
67 CENTRAL OBESITY 36 0.0487
68 COMPLICATION OF DELIVERY 13 0.0450
69 PATHOGEN RESISTANCE 390 0.0427
70 MUSCULOSKELETAL DEFORMITY 10 0.0427
71 BACILLUS INFECTION 26 0.0411
72 PSYCHOMOTOR SKILLS IMPAIRED 106 0.0404
73 FANCONI SYNDROME ACQUIRED 69 0.0393
74 RENAL TUBULAR DYSFUNCTION 22 0.0389
75 LARYNGOMALACIA 13 0.0388
76 CHRONIC HEPATITIS C 15 0.0380
77 HAEMOPHILIC ARTHROPATHY 9 0.0377
78 CEREBRAL CALCIFICATION 10 0.0375
79 ACUTE HIV INFECTION 9 0.0364
80 SYRINGOMYELIA 10 0.0360
81 NON-ALCOHOLIC FATTY LIVER 12 0.0356
82 CONGENITAL HYDROCEPHALUS 18 0.0355
83 CLEFT LIP AND PALATE 39 0.0349
84 CD4 LYMPHOCYTES DECREASED 73 0.0341
85 LIPOHYPERTROPHY 21 0.0338
86 DEPRESSIVE SYMPTOM 119 0.0337
87 URINARY TRACT INFLAMMATION 12 0.0333
88 CONGENITAL FOOT MALFORMATION 15 0.0330
89 SYPHILIS 24 0.0330
90 DEPRESSION SUICIDAL 111 0.0320
91 ANENCEPHALY 18 0.0319
92 CONGENITAL MUSCULOSKELETAL ANOMALY 14 0.0317
93 GRAFT DYSFUNCTION 9 0.0316
94 ACQUIRED IMMUNODEFICIENCY SYNDROME 16 0.0308
95 VIRAL LOAD INCREASED 119 0.0306
96 NEURAL TUBE DEFECT 22 0.0303
97 HYPERSPLENISM 14 0.0283
98 RENAL TUBULAR DISORDER 79 0.0281
99 CONDUCTIVE DEAFNESS 9 0.0280
100 PLASMABLASTIC LYMPHOMA 10 0.0279
101 ENANTHEMA 16 0.0278
102 MITOCHONDRIAL CYTOPATHY 12 0.0273
103 CONGENITAL CYSTIC KIDNEY DISEASE 23 0.0272
104 RENAL APLASIA 19 0.0270
105 ACUTE STRESS DISORDER 9 0.0269
106 TEARFULNESS 116 0.0269
107 ANHEDONIA 708 0.0269
108 CHOROIDITIS 10 0.0267
109 EXTRAOCULAR MUSCLE PARESIS 12 0.0261
110 SINGLE FUNCTIONAL KIDNEY 17 0.0257
111 VOLVULUS 60 0.0253
112 HEPATITIS B DNA INCREASED 17 0.0252
113 PULMONARY ARTERY STENOSIS 9 0.0230
114 POLYDACTYLY 26 0.0224
115 CONGENITAL HYDRONEPHROSIS 16 0.0224
116 ENDOCARDITIS STAPHYLOCOCCAL 11 0.0223
117 ADRENAL SUPPRESSION 18 0.0214
118 HIV INFECTION 63 0.0209
119 CYTOMEGALOVIRUS CHORIORETINITIS 40 0.0205
120 CEREBRAL VENTRICLE DILATATION 23 0.0199
121 TRISOMY 21 25 0.0198
122 ECONOMIC PROBLEM 298 0.0196
123 CYSTITIS NONINFECTIVE 26 0.0194
124 LIPIDS ABNORMAL 14 0.0193
125 GASTROSCHISIS 9 0.0189
126 OSTEOPOROTIC FRACTURE 36 0.0188
127 SPINA BIFIDA 38 0.0182
128 OPHTHALMOPLEGIA 28 0.0177
129 ANAL CANCER 17 0.0175
130 SEPSIS NEONATAL 14 0.0172
131 CEREBRAL TOXOPLASMOSIS 16 0.0171
132 MALARIA 12 0.0170
133 GASTROINTESTINAL TUBE INSERTION 42 0.0168
134 OSTEOPENIA 252 0.0166
135 CUSHINGOID 53 0.0165
136 AORTIC VALVE SCLEROSIS 12 0.0164
137 GLYCOSURIA 22 0.0163
138 EROSIVE DUODENITIS 13 0.0163
139 DYSLIPIDAEMIA 82 0.0161
140 LARGE FOR DATES BABY 14 0.0159
141 LIPOATROPHY 15 0.0158
142 PREMATURE RUPTURE OF MEMBRANES 38 0.0157
143 SMALL FOR DATES BABY 78 0.0157
144 GENITAL HERPES 24 0.0157
145 OESOPHAGEAL CANDIDIASIS 62 0.0155
146 GLOMERULONEPHRITIS MEMBRANOUS 18 0.0153
147 AMNIOTIC CAVITY INFECTION 11 0.0152
148 BRONCHOPULMONARY DYSPLASIA 12 0.0149
149 FOETAL EXPOSURE DURING DELIVERY 10 0.0147
150 PYELOCALIECTASIS 14 0.0146
151 CONGENITAL HAND MALFORMATION 10 0.0146
152 MULTIPLE-DRUG RESISTANCE 44 0.0142
153 BLOOD CORTISOL DECREASED 9 0.0141
154 NODULAR REGENERATIVE HYPERPLASIA 9 0.0140
155 SUPERINFECTION BACTERIAL 11 0.0139
156 MENINGITIS CRYPTOCOCCAL 24 0.0137
157 LOW BIRTH WEIGHT BABY 108 0.0136
158 FOETAL EXPOSURE DURING PREGNANCY 1100 0.0135
159 DRUG RESISTANCE 347 0.0135
160 MICROCEPHALY 17 0.0133
161 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 14 0.0132
162 CYTOLYTIC HEPATITIS 43 0.0129
163 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 14 0.0129
164 OSTEOMALACIA 20 0.0129
165 PREMATURE LABOUR 72 0.0127
166 GLOMERULAR FILTRATION RATE ABNORMAL 18 0.0127
167 DELAYED GRAFT FUNCTION 9 0.0127
168 MYCOBACTERIUM AVIUM COMPLEX INFECTION 34 0.0127
169 RETINAL TOXICITY 13 0.0126
170 HEART TRANSPLANT REJECTION 13 0.0125
171 PSYCHOMOTOR RETARDATION 34 0.0121
172 EXPOSURE DURING PREGNANCY 744 0.0120
173 KIDNEY ENLARGEMENT 13 0.0119
174 MICROALBUMINURIA 9 0.0119
175 STRONGYLOIDIASIS 19 0.0118
176 GENE MUTATION 23 0.0116
177 GENERALISED ANXIETY DISORDER 17 0.0115
178 KLEBSIELLA SEPSIS 13 0.0115
179 PLACENTA PRAEVIA 9 0.0115
180 WHITE MATTER LESION 14 0.0111
181 NEPHROCALCINOSIS 13 0.0110
182 GASTROSTOMY 17 0.0110
183 HEPATITIS CHOLESTATIC 66 0.0109
184 POLYHYDRAMNIOS 11 0.0108
185 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 35 0.0108
186 STILLBIRTH 51 0.0105
187 PSEUDOMONAL BACTERAEMIA 9 0.0105
188 OSTEOPOROSIS 430 0.0104
189 END STAGE RENAL DISEASE 187 0.0102
190 TOXOPLASMOSIS 11 0.0102
191 BONE DENSITY DECREASED 319 0.0102
192 LIVE BIRTH 85 0.0102
193 CAESAREAN SECTION 118 0.0101
194 PORTAL HYPERTENSION 31 0.0100
195 MESENTERIC VEIN THROMBOSIS 10 0.0100
196 PREMATURE BABY 301 0.0100
197 VENTRICULAR HYPERTROPHY 24 0.0096
198 PNEUMOCYSTIS JIROVECI PNEUMONIA 21 0.0094
199 VIRAEMIA 13 0.0094
200 HEPATITIS C 113 0.0094
201 FOETAL MALFORMATION 10 0.0092
202 ATYPICAL MYCOBACTERIAL INFECTION 13 0.0092
203 FANCONI SYNDROME 13 0.0092
204 METABOLIC SYNDROME 15 0.0091
205 EYELID PTOSIS 92 0.0090
206 PRE-ECLAMPSIA 43 0.0090
207 PREMATURE DELIVERY 143 0.0090
208 HYPERLACTACIDAEMIA 24 0.0089
209 CACHEXIA 46 0.0089
210 LYMPHOCYTIC INFILTRATION 9 0.0089
211 CRYPTORCHISM 10 0.0089
212 RENAL TRANSPLANT 32 0.0088
213 SKIN STRIAE 13 0.0087
214 FOETAL DEATH 45 0.0087
215 PULMONARY TUBERCULOSIS 37 0.0087
216 ABORTION INDUCED 80 0.0085
217 ASTERIXIS 9 0.0085
218 HEPATITIS FULMINANT 25 0.0084
219 MATERNAL EXPOSURE DURING PREGNANCY 750 0.0084
220 PNEUMONIA INFLUENZAL 10 0.0084
221 TALIPES 26 0.0084
222 FAT TISSUE INCREASED 12 0.0083
223 VARICES OESOPHAGEAL 25 0.0083
224 MULTIPLE FRACTURES 134 0.0081
225 PARANOIA 140 0.0081
226 PNEUMONIA PNEUMOCOCCAL 12 0.0081
227 HYPERBILIRUBINAEMIA 82 0.0079
228 DERMATITIS EXFOLIATIVE 39 0.0078
229 RENAL TUBULAR ACIDOSIS 17 0.0078
230 MATERNAL DRUGS AFFECTING FOETUS 59 0.0077
231 DRUG INTERACTION 1216 0.0077
232 ALANINE AMINOTRANSFERASE ABNORMAL 16 0.0076
233 HYPERPARATHYROIDISM SECONDARY 19 0.0076
234 PATENT DUCTUS ARTERIOSUS 30 0.0075
235 FOETAL GROWTH RESTRICTION 45 0.0074
236 GLOMERULONEPHRITIS 18 0.0073
237 PENILE SWELLING 9 0.0073
238 HEART DISEASE CONGENITAL 26 0.0073
239 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 353 0.0073
240 GINGIVAL HYPERTROPHY 11 0.0072
241 CHRONIC KIDNEY DISEASE 548 0.0072
242 PREMATURE SEPARATION OF PLACENTA 11 0.0071
243 HEPATITIS B 43 0.0071
244 BONE LOSS 107 0.0071
245 HEPATORENAL SYNDROME 12 0.0071
246 UNDERWEIGHT 14 0.0071
247 IMMUNE THROMBOCYTOPENIC PURPURA 20 0.0071
248 HYPERURICAEMIA 29 0.0070
249 NEPHROPATHY TOXIC 79 0.0070
250 HYPERTRICHOSIS 13 0.0070
251 HEPATOCELLULAR INJURY 99 0.0070
252 ABORTION SPONTANEOUS 279 0.0070
253 MULTIPLE CONGENITAL ABNORMALITIES 10 0.0069
254 NON-HODGKIN'S LYMPHOMA 9 0.0069
255 LIVER TRANSPLANT 25 0.0069
256 HEPATIC CYTOLYSIS 87 0.0068
257 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 175 0.0068
258 GESTATIONAL DIABETES 32 0.0067
259 NEPHROPATHY 62 0.0066
260 RENAL COLIC 15 0.0066
261 ASPARTATE AMINOTRANSFERASE ABNORMAL 10 0.0066
262 EMOTIONAL DISTRESS 789 0.0065
263 DEATH NEONATAL 9 0.0065
264 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 53 0.0064
265 HYPERTRIGLYCERIDAEMIA 37 0.0063
266 ARTERIAL DISORDER 12 0.0063
267 CARDIAC MURMUR 54 0.0062
268 AORTIC VALVE DISEASE 10 0.0062
269 CYTOMEGALOVIRUS TEST POSITIVE 11 0.0062
270 HYPERLIPIDAEMIA 73 0.0061
271 ANAEMIA MACROCYTIC 13 0.0061
272 SEBORRHOEIC DERMATITIS 10 0.0060
273 STAPHYLOCOCCAL BACTERAEMIA 26 0.0060
274 INTERVERTEBRAL DISCITIS 11 0.0058
275 CEREBRAL ISCHAEMIA 30 0.0058
276 QUALITY OF LIFE DECREASED 78 0.0058
277 OSTEONECROSIS 189 0.0057
278 HYDROCEPHALUS 31 0.0057
279 APHTHOUS STOMATITIS 13 0.0056
280 VENTRICULAR SEPTAL DEFECT 32 0.0056
281 CONGESTIVE CARDIOMYOPATHY 23 0.0055
282 LIPIDS INCREASED 11 0.0054
283 CONGENITAL ANOMALY 42 0.0054
284 PROTEINURIA 103 0.0054
285 OPPORTUNISTIC INFECTION 10 0.0054
286 RENAL IMPAIRMENT 442 0.0053
287 BLOOD PHOSPHORUS DECREASED 19 0.0052
288 DECREASED ACTIVITY 56 0.0052
289 SUSPECTED COVID-19 17 0.0051
290 PSYCHOTIC DISORDER 151 0.0051
291 HEPATITIS TOXIC 13 0.0050
292 CHOLESTASIS 95 0.0049
293 HAEMOLYTIC ANAEMIA 44 0.0049
294 HYPERPARATHYROIDISM 10 0.0048
295 RENAL TUBULAR NECROSIS 47 0.0048
296 BLOOD LACTIC ACID INCREASED 25 0.0047
297 GLUCOSE TOLERANCE IMPAIRED 28 0.0047
298 VITAMIN D DEFICIENCY 46 0.0047
299 HEPATIC ENCEPHALOPATHY 44 0.0047
300 GLOMERULAR FILTRATION RATE DECREASED 57 0.0046
301 HEPATITIS ACUTE 30 0.0046
302 HEPATIC CIRRHOSIS 85 0.0045
303 NEONATAL RESPIRATORY DISTRESS SYNDROME 16 0.0045
304 MYOPATHY 39 0.0045
305 DEPRESSION 1018 0.0045
306 BLOOD CREATINE PHOSPHOKINASE INCREASED 128 0.0044
307 TOOTH LOSS 92 0.0044
308 BLOOD CREATININE INCREASED 287 0.0044
309 QUADRIPLEGIA 9 0.0044
310 SKELETAL INJURY 45 0.0043
311 PNEUMOCYSTIS JIROVECII PNEUMONIA 43 0.0043
312 HYDRONEPHROSIS 32 0.0043
313 CYTOMEGALOVIRUS VIRAEMIA 19 0.0043
314 TOXIC SKIN ERUPTION 43 0.0043
315 ASPARTATE AMINOTRANSFERASE INCREASED 226 0.0043
316 ORAL CANDIDIASIS 56 0.0042
317 RENAL FAILURE 558 0.0042
318 ALANINE AMINOTRANSFERASE INCREASED 257 0.0042
319 BLOOD BILIRUBIN INCREASED 113 0.0042
320 ATRIAL SEPTAL DEFECT 35 0.0042
321 EOSINOPHILIA 73 0.0042
322 OCULAR ICTERUS 18 0.0041
323 PROTEIN TOTAL INCREASED 11 0.0041
324 DRUG LEVEL INCREASED 67 0.0040
325 POLYDIPSIA 16 0.0040
326 CEREBRAL ATROPHY 16 0.0040
327 TREATMENT NONCOMPLIANCE 217 0.0040
328 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 15 0.0039
329 ENDOTRACHEAL INTUBATION 11 0.0039
330 FURUNCLE 31 0.0039
331 FIBROSIS 12 0.0039
332 DISSEMINATED TUBERCULOSIS 10 0.0039
333 PRESCRIBED OVERDOSE 75 0.0039
334 SPINAL COMPRESSION FRACTURE 32 0.0039
335 HEPATIC NECROSIS 14 0.0037
336 MYOSITIS 33 0.0037
337 TUMOUR LYSIS SYNDROME 32 0.0036
338 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 12 0.0036
339 LYMPHOMA 56 0.0036
340 JAUNDICE 97 0.0036
341 RASH MACULO-PAPULAR 80 0.0036
342 PYELONEPHRITIS 31 0.0036
343 HEPATOMEGALY 35 0.0036
344 ESCHERICHIA INFECTION 29 0.0035
345 AORTIC ARTERIOSCLEROSIS 9 0.0035
346 TRANSPLANT REJECTION 28 0.0035
347 MEDICATION RESIDUE 9 0.0035
348 SPEECH DISORDER DEVELOPMENTAL 10 0.0035
349 HERPES VIRUS INFECTION 20 0.0035
350 HEPATITIS B REACTIVATION 11 0.0035
351 VITAMIN B12 DEFICIENCY 14 0.0035
352 NEPHROGENIC ANAEMIA 16 0.0035
353 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 9 0.0034
354 DRUG EXPOSURE DURING PREGNANCY 116 0.0034
355 PORTAL VEIN THROMBOSIS 11 0.0034
356 CLOSTRIDIUM DIFFICILE COLITIS 36 0.0034
357 ANXIETY 965 0.0034
358 DIPLOPIA 88 0.0034
359 HYPOPHOSPHATAEMIA 25 0.0034
360 FOOT FRACTURE 64 0.0034
361 AUTOIMMUNE HEPATITIS 23 0.0033
362 HEPATOTOXICITY 73 0.0033
363 METABOLIC DISORDER 19 0.0033
364 B-CELL LYMPHOMA 11 0.0032
365 PANCYTOPENIA 180 0.0032
366 RENAL FAILURE ACUTE 136 0.0032
367 STEVENS-JOHNSON SYNDROME 71 0.0032
368 KLEBSIELLA INFECTION 16 0.0032
369 ABORTION 9 0.0031
370 HEPATIC STEATOSIS 57 0.0031
371 HEPATIC FAILURE 92 0.0030
372 ADRENAL INSUFFICIENCY 37 0.0030
373 HYPERPHAGIA 12 0.0030
374 NORMOCHROMIC NORMOCYTIC ANAEMIA 9 0.0030
375 MIXED LIVER INJURY 9 0.0030
376 MUSCLE HAEMORRHAGE 12 0.0030
377 PANCREATITIS ACUTE 67 0.0030
378 PRODUCT SIZE ISSUE 16 0.0030
379 HEPATITIS 76 0.0030
380 ATRIOVENTRICULAR BLOCK SECOND DEGREE 9 0.0030
381 BK VIRUS INFECTION 10 0.0030
382 HAND FRACTURE 21 0.0030
383 RENAL INJURY 88 0.0030
384 NORMAL NEWBORN 16 0.0029
385 PHLEBITIS 15 0.0029
386 MATERNAL EXPOSURE TIMING UNSPECIFIED 11 0.0029
387 GAMMA-GLUTAMYLTRANSFERASE INCREASED 64 0.0029
388 TRANSAMINASES INCREASED 64 0.0029
389 FACE OEDEMA 48 0.0028
390 UMBILICAL HERNIA 13 0.0028
391 RHABDOMYOLYSIS 116 0.0028
392 NEPHROTIC SYNDROME 19 0.0028
393 LYMPHOPENIA 39 0.0028
394 ASCITES 81 0.0028
395 DRUG LEVEL DECREASED 28 0.0027
396 LIPASE INCREASED 21 0.0027
397 VENTRICULAR ARRHYTHMIA 10 0.0027
398 DIFFUSE LARGE B-CELL LYMPHOMA 21 0.0027
399 PARADOXICAL DRUG REACTION 10 0.0027
400 HYPERCHOLESTEROLAEMIA 26 0.0027
401 BONE DENSITY ABNORMAL 10 0.0027
402 TREATMENT FAILURE 221 0.0027
403 ACUTE KIDNEY INJURY 405 0.0026
404 DRUG-INDUCED LIVER INJURY 83 0.0026
405 AUTOIMMUNE THYROIDITIS 10 0.0026
406 MATERNAL EXPOSURE BEFORE PREGNANCY 18 0.0026
407 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 45 0.0026
408 TUBULOINTERSTITIAL NEPHRITIS 49 0.0026
409 BLOOD IRON DECREASED 31 0.0026
410 EXERCISE TOLERANCE DECREASED 15 0.0026
411 BLOOD CREATININE ABNORMAL 9 0.0026
412 RENAL DISORDER 121 0.0026
413 AORTIC STENOSIS 9 0.0026
414 NEPHROLITHIASIS 118 0.0026
415 RASH GENERALISED 66 0.0025
416 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 13 0.0025
417 BENIGN PROSTATIC HYPERPLASIA 13 0.0025
418 SUBCUTANEOUS ABSCESS 12 0.0025
419 BLOOD ALKALINE PHOSPHATASE INCREASED 62 0.0025
420 SKIN PAPILLOMA 10 0.0025
421 HEPATIC FUNCTION ABNORMAL 93 0.0025
422 CYTOMEGALOVIRUS INFECTION REACTIVATION 11 0.0025
423 MALABSORPTION 13 0.0025
424 ANGINA UNSTABLE 16 0.0025
425 BRONCHOPULMONARY ASPERGILLOSIS 19 0.0024
426 PERIPHERAL VENOUS DISEASE 10 0.0024
427 BLOOD TRIGLYCERIDES INCREASED 43 0.0024
428 STAPHYLOCOCCAL SEPSIS 12 0.0024
429 MULTI-ORGAN FAILURE 42 0.0024
430 HAEMATOTOXICITY 23 0.0024
431 EMBOLISM 20 0.0024
432 ANAEMIA 459 0.0024
433 GASTROENTERITIS 35 0.0024
434 HYPOVOLAEMIA 14 0.0024
435 ANKLE FRACTURE 37 0.0024
436 INTERVERTEBRAL DISC DEGENERATION 22 0.0024
437 ERECTILE DYSFUNCTION 61 0.0024
438 SLEEP TERROR 10 0.0024
439 HEPATOCELLULAR CARCINOMA 18 0.0024
440 CYTOMEGALOVIRUS INFECTION 39 0.0023
441 TIBIA FRACTURE 11 0.0023
442 ACUTE HEPATIC FAILURE 32 0.0023
443 LIVER FUNCTION TEST ABNORMAL 68 0.0023
444 WRIST FRACTURE 28 0.0023
445 RIB FRACTURE 48 0.0023
446 TYPE 1 DIABETES MELLITUS 14 0.0023
447 LYMPHOEDEMA 16 0.0023
448 ENCEPHALITIS 16 0.0023
449 APNOEA 18 0.0023
450 CERVIX CARCINOMA 9 0.0023
451 HUMERUS FRACTURE 11 0.0023
452 SUICIDAL IDEATION 208 0.0023
453 NYSTAGMUS 12 0.0023
454 PHARYNGITIS 28 0.0023
455 MENINGITIS 15 0.0022
456 EPSTEIN-BARR VIRUS INFECTION 14 0.0022
457 LIVER DISORDER 99 0.0022
458 HYPOTONIA 22 0.0022
459 DRUG ERUPTION 39 0.0022
460 CANDIDA INFECTION 37 0.0022
461 AUTISM SPECTRUM DISORDER 12 0.0022
462 BUNDLE BRANCH BLOCK RIGHT 10 0.0022
463 RENAL CYST 17 0.0021
464 STATUS EPILEPTICUS 24 0.0021
465 GENERALISED ERYTHEMA 12 0.0021
466 NEUROLOGICAL SYMPTOM 12 0.0021
467 DYSPHAGIA 199 0.0021
468 MEDICATION RESIDUE PRESENT 10 0.0021
469 POLYURIA 17 0.0021
470 LACTIC ACIDOSIS 65 0.0020
471 PROTEIN URINE PRESENT 10 0.0020
472 ACUTE MYOCARDIAL INFARCTION 59 0.0020
473 DISSEMINATED INTRAVASCULAR COAGULATION 28 0.0020
474 NERVOUS SYSTEM DISORDER 62 0.0020
475 NO ADVERSE EVENT 358 0.0020
476 MALNUTRITION 22 0.0020
477 NEUROTOXICITY 34 0.0019
478 METABOLIC ACIDOSIS 62 0.0019
479 SPINAL OSTEOARTHRITIS 17 0.0019
480 DIABETES MELLITUS 147 0.0019
481 EOSINOPHIL COUNT INCREASED 16 0.0019
482 DYSSTASIA 56 0.0019
483 SOCIAL AVOIDANT BEHAVIOUR 11 0.0019
484 HYPERKALAEMIA 66 0.0019
485 SPLENOMEGALY 22 0.0019
486 PANCREATITIS 99 0.0019
487 PSEUDOMONAS INFECTION 16 0.0019
488 PULMONARY ARTERIAL HYPERTENSION 27 0.0019
489 ADVERSE EVENT 170 0.0018
490 THROMBOCYTOPENIA 205 0.0018
491 DIALYSIS 26 0.0018
492 ACIDOSIS 14 0.0018
493 NEUROPATHY PERIPHERAL 173 0.0018
494 LYMPHADENOPATHY 64 0.0018
495 SUDDEN DEATH 19 0.0018
496 HAEMORRHAGIC STROKE 14 0.0018
497 RENAL PAIN 19 0.0018
498 ENCEPHALOPATHY 44 0.0018
499 ERYSIPELAS 9 0.0018
500 RESPIRATORY DISTRESS 49 0.0018
501 CHOLANGITIS 11 0.0018
502 PSYCHIATRIC SYMPTOM 13 0.0018
503 INFARCTION 12 0.0018
504 PRURITUS GENERALISED 37 0.0017
505 PERIPHERAL SENSORY NEUROPATHY 10 0.0017
506 SQUAMOUS CELL CARCINOMA 16 0.0017
507 PREGNANCY 34 0.0017
508 HIP ARTHROPLASTY 26 0.0017
509 HERPES SIMPLEX 11 0.0017
510 FRACTURE 32 0.0017
511 ACUTE CORONARY SYNDROME 14 0.0017
512 LOWER LIMB FRACTURE 32 0.0017
513 CHEILITIS 9 0.0017
514 BRAIN OEDEMA 21 0.0017
515 MYOCARDITIS 19 0.0017
516 LEUKOPENIA 82 0.0016
517 PNEUMONIA BACTERIAL 15 0.0016
518 TOOTH FRACTURE 18 0.0016
519 NEUTROPENIA 222 0.0016
520 CEREBRAL DISORDER 12 0.0016
521 GENERAL PHYSICAL CONDITION ABNORMAL 11 0.0016
522 INTENTIONAL PRODUCT USE ISSUE 141 0.0016
523 SEPTIC SHOCK 70 0.0016
524 MYOCLONUS 19 0.0016
525 HYPERGLYCAEMIA 58 0.0016
526 MUCOSAL INFLAMMATION 41 0.0016
527 RENAL FAILURE CHRONIC 12 0.0016
528 BLOOD URIC ACID INCREASED 9 0.0016
529 UROSEPSIS 14 0.0015
530 MAJOR DEPRESSION 11 0.0015
531 MITRAL VALVE INCOMPETENCE 17 0.0015
532 CARDIAC FAILURE ACUTE 10 0.0015
533 NEOPLASM PROGRESSION 52 0.0015
534 PAIN 917 0.0015
535 POST-TRAUMATIC STRESS DISORDER 10 0.0015
536 GASTRIC ULCER 28 0.0015
537 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
538 BLOOD TESTOSTERONE DECREASED 10 0.0015
539 SKIN LESION 40 0.0015
540 PIGMENTATION DISORDER 9 0.0015
541 AFFECT LABILITY 14 0.0015
542 BLOOD LACTATE DEHYDROGENASE INCREASED 23 0.0015
543 LOW DENSITY LIPOPROTEIN INCREASED 11 0.0014
544 POLYNEUROPATHY 17 0.0014
545 SPINAL FRACTURE 28 0.0014
546 TYPE 2 DIABETES MELLITUS 47 0.0014
547 MUSCLE STRAIN 12 0.0014
548 TOXIC EPIDERMAL NECROLYSIS 21 0.0014
549 ARTERIOSCLEROSIS 13 0.0014
550 ABNORMAL DREAMS 38 0.0014
551 UTERINE LEIOMYOMA 10 0.0014
552 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
553 SHOCK HAEMORRHAGIC 11 0.0013
554 ATAXIA 16 0.0013
555 HAEMATURIA 46 0.0013
556 MUSCLE ATROPHY 17 0.0013
557 WRONG TECHNIQUE IN DRUG USAGE PROCESS 48 0.0013
558 OPTIC NEURITIS 12 0.0013
559 SHOCK 30 0.0013
560 IRON DEFICIENCY ANAEMIA 12 0.0013
561 HYPOKALAEMIA 60 0.0013
562 HYPERCALCAEMIA 16 0.0013
563 POLLAKIURIA 54 0.0013
564 HEPATIC ENZYME INCREASED 88 0.0013
565 MASS 18 0.0013
566 FLANK PAIN 12 0.0013
567 BONE MARROW FAILURE 26 0.0013
568 IMMUNODEFICIENCY 19 0.0013
569 CEREBRAL INFARCTION 31 0.0013
570 HELICOBACTER INFECTION 13 0.0013
571 BACTERAEMIA 15 0.0013
572 LIVER INJURY 31 0.0013
573 ANGINA PECTORIS 36 0.0013
574 CHOLELITHIASIS 41 0.0012
575 DRUG TOXICITY 17 0.0012
576 FOLLICULITIS 13 0.0012
577 MYOCARDIAL ISCHAEMIA 14 0.0012
578 OSTEOARTHRITIS 52 0.0012
579 THERAPY CHANGE 12 0.0012
580 CARDIOMEGALY 15 0.0012
581 HICCUPS 10 0.0012
582 IMPAIRED WORK ABILITY 26 0.0012
583 PYREXIA 416 0.0012
584 SEPSIS 134 0.0012
585 SKIN ULCER 31 0.0012
586 DYSURIA 44 0.0012
587 GRAND MAL CONVULSION 11 0.0012
588 AGRANULOCYTOSIS 22 0.0012
589 MYALGIA 200 0.0012
590 ANURIA 10 0.0012
591 BASAL CELL CARCINOMA 18 0.0012
592 HIP FRACTURE 37 0.0011
593 REBOUND EFFECT 13 0.0011
594 PRODUCT USE COMPLAINT 18 0.0011
595 CARPAL TUNNEL SYNDROME 16 0.0011
596 IMMUNOSUPPRESSION 10 0.0011
597 VERTIGO 69 0.0011
598 SOPOR 15 0.0011
599 GENERALISED OEDEMA 14 0.0011
600 MOBILITY DECREASED 80 0.0011
601 MENTAL DISORDER 48 0.0011
602 FEBRILE NEUTROPENIA 73 0.0011
603 BONE DISORDER 20 0.0011
604 CENTRAL NERVOUS SYSTEM LESION 15 0.0011
605 CELLULITIS 55 0.0011
606 ORTHOSTATIC HYPOTENSION 19 0.0011
607 GENERALISED TONIC-CLONIC SEIZURE 18 0.0011
608 HYPONATRAEMIA 61 0.0011
609 CARDIOMYOPATHY 16 0.0011
610 HALLUCINATION, AUDITORY 17 0.0011
611 OBESITY 17 0.0011
612 VENTRICULAR EXTRASYSTOLES 11 0.0011
613 CORONARY ARTERY DISEASE 32 0.0011
614 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
615 CARDIAC OPERATION 9 0.0010
616 MUSCULOSKELETAL DISCOMFORT 18 0.0010
617 GAIT DISTURBANCE 200 0.0010
618 NIGHTMARE 36 0.0010
619 DERMATITIS ALLERGIC 13 0.0010
620 ELECTROLYTE IMBALANCE 12 0.0010
621 THERAPY NON-RESPONDER 46 0.0010
622 LUNG INFILTRATION 9 0.0010
623 BLOOD UREA INCREASED 17 0.0010
624 RASH PRURITIC 55 0.0010
625 DYSARTHRIA 38 0.0010
626 INSOMNIA 267 0.0010
627 LOSS OF LIBIDO 9 0.0010
628 IMMUNE SYSTEM DISORDER 13 0.0010
629 SINUS TACHYCARDIA 14 0.0010
630 RASH PAPULAR 22 0.0010
631 EPILEPSY 30 0.0010
632 BLOOD THYROID STIMULATING HORMONE INCREASED 9 0.0010
633 RESPIRATORY FAILURE 71 0.0010
634 TENDON RUPTURE 12 0.0010
635 MYELODYSPLASTIC SYNDROME 14 0.0010
636 HYPERTHYROIDISM 14 0.0010
637 PRODUCT AVAILABILITY ISSUE 22 0.0010
638 DIABETES MELLITUS INADEQUATE CONTROL 17 0.0010
639 HERPES ZOSTER 55 0.0010
640 UPPER LIMB FRACTURE 19 0.0010
641 MYOCARDIAL INFARCTION 166 0.0010
642 DEPRESSED MOOD 50 0.0009
643 HEMIPARESIS 16 0.0009
644 NIGHT SWEATS 30 0.0009
645 BLOOD POTASSIUM INCREASED 15 0.0009
646 OEDEMA 50 0.0009
647 HYPERTENSION 195 0.0009
648 ELECTROCARDIOGRAM QT PROLONGED 33 0.0009
649 CONJUNCTIVITIS 17 0.0009
650 INTERVERTEBRAL DISC PROTRUSION 20 0.0009
651 PULMONARY HYPERTENSION 19 0.0009
652 OESOPHAGEAL CARCINOMA 27 0.0009
653 NOCTURIA 11 0.0009
654 SCHIZOPHRENIA 11 0.0009
655 NO THERAPEUTIC RESPONSE 11 0.0009
656 ASTHENIA 339 0.0009
657 VENTRICULAR FIBRILLATION 10 0.0009
658 DELIRIUM 31 0.0009
659 BONE PAIN 52 0.0009
660 PRODUCT USE IN UNAPPROVED INDICATION 220 0.0009
661 ACUTE RESPIRATORY FAILURE 17 0.0009
662 TOXICITY TO VARIOUS AGENTS 148 0.0009
663 SUICIDE ATTEMPT 53 0.0009
664 FEMUR FRACTURE 27 0.0009
665 TINNITUS 40 0.0009
666 MENTAL STATUS CHANGES 24 0.0009
667 WEIGHT INCREASED 193 0.0009
668 LOCAL SWELLING 15 0.0009
669 LUNG DISORDER 42 0.0009
670 FEAR 23 0.0009
671 SLEEP DISORDER 60 0.0008
672 PHOTOSENSITIVITY REACTION 14 0.0008
673 GENERAL PHYSICAL HEALTH DETERIORATION 98 0.0008
674 INTERSTITIAL LUNG DISEASE 41 0.0008
675 COAGULOPATHY 14 0.0008
676 CHOLECYSTITIS 10 0.0008
677 CARDIOGENIC SHOCK 12 0.0008
678 MUSCULAR WEAKNESS 95 0.0008
679 DRUG PRESCRIBING ERROR 16 0.0008
680 ABDOMINAL PAIN 193 0.0008
681 APATHY 12 0.0008
682 THROMBOSIS 66 0.0008
683 DIARRHOEA 527 0.0008
684 BLOOD CHOLESTEROL INCREASED 38 0.0008
685 UVEITIS 11 0.0008
686 CARDIAC FAILURE 65 0.0008
687 MOUTH ULCERATION 17 0.0008
688 TOOTH EXTRACTION 10 0.0008
689 INTESTINAL PERFORATION 9 0.0008
690 DYSPNOEA EXERTIONAL 30 0.0008
691 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
692 HAEMATEMESIS 20 0.0008
693 CHOLECYSTECTOMY 9 0.0008
694 VENTRICULAR TACHYCARDIA 13 0.0008
695 DRUG DISPENSING ERROR 12 0.0008
696 RASH 342 0.0008
697 NEURALGIA 19 0.0008
698 TENDONITIS 12 0.0008
699 CONVULSION 44 0.0008
700 DEAFNESS 20 0.0008
701 NEUTROPHIL COUNT DECREASED 31 0.0008
702 DISEASE RECURRENCE 36 0.0008
703 TACHYCARDIA 67 0.0008
704 PALPITATIONS 88 0.0008
705 COGNITIVE DISORDER 35 0.0007
706 DIABETIC KETOACIDOSIS 18 0.0007
707 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 39 0.0007
708 INTENTIONAL SELF-INJURY 15 0.0007
709 PANIC ATTACK 27 0.0007
710 COLITIS 28 0.0007
711 ALTERED STATE OF CONSCIOUSNESS 16 0.0007
712 SEIZURE 85 0.0007
713 TACHYPNOEA 10 0.0007
714 MOOD ALTERED 20 0.0007
715 MANIA 12 0.0007
716 CORONARY ARTERY OCCLUSION 10 0.0007
717 GLAUCOMA 14 0.0007
718 VOMITING 341 0.0007
719 CYST 9 0.0007
720 DRUG INTOLERANCE 70 0.0007
721 GOUT 13 0.0007
722 DRUG ABUSE 60 0.0007
723 WEIGHT DECREASED 201 0.0007
724 LEUKOCYTOSIS 13 0.0007
725 HAEMORRHOIDS 14 0.0007
726 COLITIS ULCERATIVE 32 0.0007
727 PULMONARY EMBOLISM 68 0.0007
728 CARDIAC ARREST 59 0.0007
729 LOWER RESPIRATORY TRACT INFECTION 32 0.0007
730 GASTROINTESTINAL DISORDER 63 0.0007
731 ANGIOEDEMA 31 0.0007
732 POOR QUALITY SLEEP 15 0.0007
733 HALLUCINATION 52 0.0007
734 FATIGUE 530 0.0007
735 PNEUMONIA ASPIRATION 17 0.0007
736 ILL-DEFINED DISORDER 41 0.0007
737 PNEUMONIA 218 0.0007
738 THIRST 12 0.0007
739 RESPIRATORY DISORDER 20 0.0007
740 DERMATITIS 14 0.0007
741 AGITATION 49 0.0007
742 CHOKING 13 0.0007
743 HAEMOGLOBIN DECREASED 68 0.0007
744 AMNESIA 43 0.0007
745 DECREASED APPETITE 153 0.0007
746 HAEMATOMA 17 0.0007
747 LIVER FUNCTION TEST INCREASED 14 0.0007
748 SKIN EXFOLIATION 55 0.0007
749 RECTAL HAEMORRHAGE 28 0.0007
750 COMA 31 0.0007
751 LABORATORY TEST ABNORMAL 19 0.0006
752 LUNG INFECTION 10 0.0006
753 PRODUCT DOSE OMISSION 42 0.0006
754 CATARACT 38 0.0006
755 HYPERSENSITIVITY 118 0.0006
756 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
757 ABDOMINAL DISTENSION 66 0.0006
758 OEDEMA PERIPHERAL 77 0.0006
759 MUSCULOSKELETAL DISORDER 12 0.0006
760 PLEURAL EFFUSION 38 0.0006
761 CHROMATURIA 14 0.0006
762 HEART RATE IRREGULAR 14 0.0006
763 PLATELET COUNT DECREASED 66 0.0006
764 NEOPLASM MALIGNANT 41 0.0006
765 CARDIAC FAILURE CONGESTIVE 49 0.0006
766 HAEMATOCRIT DECREASED 12 0.0006
767 C-REACTIVE PROTEIN INCREASED 22 0.0006
768 COLON CANCER 9 0.0006
769 BRADYCARDIA 32 0.0006
770 PSYCHOMOTOR HYPERACTIVITY 10 0.0006
771 FAECES DISCOLOURED 13 0.0006
772 IRRITABILITY 36 0.0006
773 INTERNATIONAL NORMALISED RATIO INCREASED 17 0.0006
774 NAUSEA 471 0.0006
775 DISTURBANCE IN ATTENTION 32 0.0006
776 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 20 0.0006
777 DEHYDRATION 78 0.0006
778 BACK PAIN 135 0.0006
779 GASTROINTESTINAL HAEMORRHAGE 48 0.0006
780 DYSPEPSIA 56 0.0006
781 METASTASES TO LIVER 10 0.0006
782 HYPOAESTHESIA 85 0.0006
783 PNEUMOTHORAX 9 0.0006
784 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
785 HEAD DISCOMFORT 10 0.0006
786 MUSCLE TWITCHING 13 0.0006
787 EATING DISORDER 12 0.0006
788 ORAL HERPES 11 0.0006
789 OFF LABEL USE 486 0.0006
790 PRODUCT PRESCRIBING ISSUE 12 0.0006
791 DRUG DOSE OMISSION 91 0.0005
792 GYNAECOMASTIA 17 0.0005
793 ARRHYTHMIA 26 0.0005
794 PRODUCT PHYSICAL ISSUE 11 0.0005
795 URINARY TRACT INFECTION 93 0.0005
796 FEEDING DISORDER 11 0.0005
797 DEATH 466 0.0005
798 CONDITION AGGRAVATED 164 0.0005
799 DEMENTIA 15 0.0005
800 PERICARDITIS 9 0.0005
801 PRESYNCOPE 13 0.0005
802 MOVEMENT DISORDER 17 0.0005
803 ARTHRALGIA 218 0.0005
804 INCREASED APPETITE 10 0.0005
805 PRURITUS 201 0.0005
806 DRUG ADMINISTRATION ERROR 16 0.0005
807 PARAESTHESIA 82 0.0005
808 OROPHARYNGEAL PAIN 48 0.0005
809 LYMPHOCYTE COUNT DECREASED 9 0.0005
810 WHITE BLOOD CELL COUNT DECREASED 55 0.0005
811 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
812 DISORIENTATION 20 0.0005
813 ISCHAEMIC STROKE 9 0.0005
814 CEREBRAL HAEMORRHAGE 18 0.0005
815 MOOD SWINGS 16 0.0005
816 INFLUENZA LIKE ILLNESS 41 0.0005
817 OSTEOMYELITIS 9 0.0005
818 GASTROOESOPHAGEAL REFLUX DISEASE 40 0.0005
819 GASTRITIS 13 0.0005
820 HEADACHE 309 0.0005
821 SWELLING FACE 32 0.0005
822 CHEST PAIN 89 0.0005
823 PHOTOPHOBIA 9 0.0005
824 BLOOD SODIUM DECREASED 9 0.0005
825 MUSCULOSKELETAL PAIN 25 0.0005
826 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
827 INCORRECT ROUTE OF DRUG ADMINISTRATION 17 0.0005
828 FALL 158 0.0005
829 ANGER 16 0.0005
830 BRONCHITIS 35 0.0005
831 PROSTATE CANCER 38 0.0005
832 CEREBROVASCULAR ACCIDENT 80 0.0005
833 INFECTION 68 0.0005
834 WHITE BLOOD CELL COUNT INCREASED 18 0.0005
835 INTENTIONAL OVERDOSE 30 0.0005
836 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 33 0.0005
837 HYPOTENSION 93 0.0005
838 EAR PAIN 9 0.0005
839 STOMATITIS 28 0.0005
840 RASH ERYTHEMATOUS 22 0.0005
841 PRODUCT DISPENSING ERROR 10 0.0005
842 CONFUSIONAL STATE 74 0.0005
843 PAIN IN EXTREMITY 134 0.0005
844 STAPHYLOCOCCAL INFECTION 15 0.0005
845 ABNORMAL BEHAVIOUR 18 0.0005
846 MALAISE 198 0.0005
847 INTESTINAL OBSTRUCTION 17 0.0005
848 HAEMORRHAGE 47 0.0004
849 NECK PAIN 25 0.0004
850 DEEP VEIN THROMBOSIS 29 0.0004
851 PRODUCT ADMINISTRATION ERROR 9 0.0004
852 BLISTER 25 0.0004
853 HEAD INJURY 14 0.0004
854 COUGH 124 0.0004
855 FLATULENCE 25 0.0004
856 RESTLESSNESS 16 0.0004
857 GASTRIC DISORDER 15 0.0004
858 OVERDOSE 94 0.0004
859 FLUID RETENTION 22 0.0004
860 BLOOD POTASSIUM DECREASED 13 0.0004
861 MEDICATION ERROR 24 0.0004
862 DIZZINESS 215 0.0004
863 APHASIA 13 0.0004
864 HYPOPHAGIA 11 0.0004
865 BALANCE DISORDER 37 0.0004
866 HYPOXIA 15 0.0004
867 HOSPITALISATION 65 0.0004
868 SOMNOLENCE 85 0.0004
869 INFLUENZA 47 0.0004
870 PRODUCT USE ISSUE 79 0.0004
871 URINARY RETENTION 14 0.0004
872 ARTHRITIS 33 0.0004
873 HYPERSOMNIA 12 0.0004
874 LETHARGY 24 0.0004
875 MEMORY IMPAIRMENT 57 0.0004
876 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
877 ABASIA 10 0.0004
878 DYSPNOEA 229 0.0004
879 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
880 CHILLS 47 0.0004
881 FEELING COLD 11 0.0004
882 VISUAL ACUITY REDUCED 13 0.0004
883 LIP SWELLING 13 0.0004
884 SWOLLEN TONGUE 12 0.0004
885 RESPIRATORY TRACT INFECTION 10 0.0004
886 CARDIO-RESPIRATORY ARREST 16 0.0004
887 LOSS OF CONSCIOUSNESS 48 0.0004
888 RASH MACULAR 13 0.0004
889 MENTAL IMPAIRMENT 9 0.0004
890 SYNCOPE 37 0.0004
891 INFLAMMATION 19 0.0004
892 PALLOR 10 0.0004
893 LUNG NEOPLASM MALIGNANT 15 0.0004
894 ERYTHEMA 75 0.0004
895 CARDIAC DISORDER 34 0.0004
896 EPISTAXIS 27 0.0004
897 ROAD TRAFFIC ACCIDENT 15 0.0004
898 CRYING 13 0.0004
899 PULMONARY OEDEMA 16 0.0004
900 EMOTIONAL DISORDER 11 0.0004
901 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
902 ACCIDENTAL OVERDOSE 13 0.0004
903 RED BLOOD CELL COUNT DECREASED 10 0.0003
904 ABDOMINAL PAIN UPPER 72 0.0003
905 HYPERHIDROSIS 45 0.0003
906 ADVERSE DRUG REACTION 31 0.0003
907 DRY MOUTH 28 0.0003
908 JOINT STIFFNESS 9 0.0003
909 URINARY INCONTINENCE 10 0.0003
910 TREMOR 55 0.0003
911 HYPOGLYCAEMIA 16 0.0003
912 VISUAL IMPAIRMENT 40 0.0003
913 EYE SWELLING 12 0.0003
914 DRUG INEFFECTIVE 425 0.0003
915 ABDOMINAL DISCOMFORT 54 0.0003
916 DYSKINESIA 13 0.0003
917 PAIN IN JAW 9 0.0003
918 UNEVALUABLE EVENT 24 0.0003
919 THERAPEUTIC RESPONSE DECREASED 19 0.0003
920 INJURY 22 0.0003
921 DISEASE PROGRESSION 37 0.0003
922 PANCREATIC CARCINOMA 9 0.0003
923 SWELLING 29 0.0003
924 RHINORRHOEA 20 0.0003
925 MUSCULOSKELETAL STIFFNESS 27 0.0003
926 BLOOD GLUCOSE INCREASED 57 0.0003
927 SKIN DISORDER 10 0.0003
928 NASOPHARYNGITIS 55 0.0003
929 ATRIAL FIBRILLATION 29 0.0003
930 DISCOMFORT 18 0.0003
931 BLINDNESS 12 0.0003
932 URTICARIA 49 0.0003
933 THERAPY CESSATION 15 0.0003
934 MUSCLE SPASMS 53 0.0003
935 VISION BLURRED 39 0.0003
936 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 57 0.0003
937 AGGRESSION 14 0.0003
938 FEELING ABNORMAL 66 0.0003
939 UNDERDOSE 20 0.0003
940 MALIGNANT NEOPLASM PROGRESSION 28 0.0003
941 MIGRAINE 26 0.0003
942 PRODUCTIVE COUGH 13 0.0003
943 CONSTIPATION 59 0.0003
944 GAIT INABILITY 9 0.0003
945 NERVOUSNESS 14 0.0003
946 OXYGEN SATURATION DECREASED 15 0.0003
947 SURGERY 15 0.0003
948 DYSGEUSIA 19 0.0003
949 SINUSITIS 26 0.0003
950 ARTHROPATHY 14 0.0003
951 SPEECH DISORDER 13 0.0002
952 DRY EYE 12 0.0002
953 PRODUCT QUALITY ISSUE 32 0.0002
954 BLOOD PRESSURE INCREASED 36 0.0002
955 ECZEMA 12 0.0002
956 DRUG EFFECT DECREASED 12 0.0002
957 HAEMATOCHEZIA 12 0.0002
958 EYE PAIN 12 0.0002
959 HOT FLUSH 16 0.0002
960 PRODUCT DOSE OMISSION ISSUE 61 0.0002
961 INCORRECT DOSE ADMINISTERED 47 0.0002
962 INTENTIONAL PRODUCT MISUSE 18 0.0002
963 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 36 0.0002
964 BLOOD PRESSURE DECREASED 13 0.0002
965 PERIPHERAL SWELLING 30 0.0002
966 INJECTION SITE REACTION 13 0.0002
967 RENAL CANCER 9 0.0002
968 ALOPECIA 37 0.0002
969 CONTUSION 18 0.0002
970 BURNING SENSATION 13 0.0002
971 JOINT SWELLING 22 0.0002
972 HEART RATE INCREASED 18 0.0002
973 COMPLETED SUICIDE 15 0.0002
974 DRY SKIN 23 0.0002
975 COVID-19 30 0.0002
976 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
977 PRODUCT SUBSTITUTION ISSUE 9 0.0002
978 DYSPHONIA 9 0.0002
979 ASTHMA 17 0.0002
980 FLUSHING 15 0.0001
981 CHEST DISCOMFORT 15 0.0001
982 DRUG WITHDRAWAL SYNDROME 11 0.0001
983 PRODUCT STORAGE ERROR 10 0.0001
984 PSORIASIS 14 0.0001
985 ILLNESS 9 0.0001
986 INJECTION SITE ERYTHEMA 10 0.0001
987 DRUG DEPENDENCE 10 0.0001
988 INJECTION SITE PAIN 19 0.0001